Current Trends in Monoclonal Antibody Development and Manufacturing (Paperback)

Edité par Springer-Verlag New York Inc., 2012
ISBN 10: 1461424917 / ISBN 13: 9781461424918
Ancien(s) ou d'occasion / Paperback / Quantité : 0
Disponible auprès d'autres vendeurs
Afficher tous les  exemplaires de ce livre

Au sujet du livre

Ce livre n'est malheureusement plus disponible. AbeBooks dispose cependant de millions de livres. Ci-dessous, nous vous proposons une liste de livres pouvant correspondre à votre recherche.

Description :

Language: English . Brand New Book. Monoclonal antibodies represent one of the fastest growing areas of new drug development within the pharmaceutical industry. Several blockbuster products have been approved over the past several years including Rituxan, Remicade, Avastin, Humira, and Herceptin. In addition, over 300 new drugs are currently in clinical trials. With both large, established biotechnology companies and small start-ups involved in the development of this important class of molecules, monoclonal antibodies products will become increasingly prevalent over the next decade. Recently the regulatory review of monoclonal antibodies has been moved from Center for Biologics and Research to the Center for Drug Evaluation and Research (CDER) division of the US Food and Drug Administration. It is anticipated that CDER will expect a certain minimal amount of data to be provided as more of these products move through the regulatory pipeline. Current Trends in Monoclonal Antibody Development and Manufacturing will provide readers with an understanding of what is currently being done in the industry to develop, manufacture, and release monoclonal antibody products and what will be required for a successful regulatory submission. N° de réf. du libraire

A propos du livre :

Book ratings provided by GoodReads) :
2 note moyenne
(1 avis)

Synopsis :

Monoclonal antibodies represent one of the fastest growing areas of new drug development within the pharmaceutical industry. Several blockbuster products have been approved over the past several years including Rituxan, Remicade, Avastin, Humira, and Herceptin. In addition, over 300 new drugs are currently in clinical trials. With both large, established biotechnology companies and small start-ups involved in the development of this important class of molecules, monoclonal antibodies products will become increasingly prevalent over the next decade.

Recently the regulatory review of monoclonal antibodies has been moved from Center for Biologics and Research to the Center for Drug Evaluation and Research (CDER) division of the US Food and Drug Administration. It is anticipated that CDER will expect a certain minimal amount of data to be provided as more of these products move through the regulatory pipeline. Current Trends in Monoclonal Antibody Development and Manufacturing will provide readers with an understanding of what is currently being done in the industry to develop, manufacture, and release monoclonal antibody products and what will be required for a successful regulatory submission.

Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.

Détails bibliographiques

Titre : Current Trends in Monoclonal Antibody ...
Éditeur : Springer-Verlag New York Inc.
Date d'édition : 2012
Reliure : Paperback
Etat du livre : New
Edition : 2010 ed..

Meilleurs résultats de recherche sur AbeBooks

1.

Steve Shire
Edité par Springer-Verlag New York Inc. (2012)
ISBN 10 : 1461424917 ISBN 13 : 9781461424918
Neuf(s) Quantité : > 20
impression à la demande
Vendeur
Books2Anywhere
(Fairford, GLOS, Royaume-Uni)
Evaluation vendeur
[?]

Description du livre Springer-Verlag New York Inc., 2012. PAP. État : New. New Book. Delivered from our US warehouse in 10 to 14 business days. THIS BOOK IS PRINTED ON DEMAND.Established seller since 2000. N° de réf. du libraire IP-9781461424918

Plus d'informations sur ce vendeur | Poser une question au libraire

Acheter neuf
EUR 243,77
Autre devise

Ajouter au panier

Frais de port : EUR 11,76
De Royaume-Uni vers France
Destinations, frais et délais

2.

Edité par Springer-Verlag New York Inc., United States (2012)
ISBN 10 : 1461424917 ISBN 13 : 9781461424918
Neuf(s) Paperback Quantité : 10
impression à la demande
Vendeur
The Book Depository
(London, Royaume-Uni)
Evaluation vendeur
[?]

Description du livre Springer-Verlag New York Inc., United States, 2012. Paperback. État : New. 2010 ed.. 254 x 178 mm. Language: English . Brand New Book ***** Print on Demand *****.Monoclonal antibodies represent one of the fastest growing areas of new drug development within the pharmaceutical industry. Several blockbuster products have been approved over the past several years including Rituxan, Remicade, Avastin, Humira, and Herceptin. In addition, over 300 new drugs are currently in clinical trials. With both large, established biotechnology companies and small start-ups involved in the development of this important class of molecules, monoclonal antibodies products will become increasingly prevalent over the next decade. Recently the regulatory review of monoclonal antibodies has been moved from Center for Biologics and Research to the Center for Drug Evaluation and Research (CDER) division of the US Food and Drug Administration. It is anticipated that CDER will expect a certain minimal amount of data to be provided as more of these products move through the regulatory pipeline.Current Trends in Monoclonal Antibody Development and Manufacturing will provide readers with an understanding of what is currently being done in the industry to develop, manufacture, and release monoclonal antibody products and what will be required for a successful regulatory submission. N° de réf. du libraire AAV9781461424918

Plus d'informations sur ce vendeur | Poser une question au libraire

Acheter neuf
EUR 247,14
Autre devise

Ajouter au panier

Frais de port : EUR 1,41
De Royaume-Uni vers France
Destinations, frais et délais

3.

STEVEN J. SHIRE
Edité par Springer (2012)
ISBN 10 : 1461424917 ISBN 13 : 9781461424918
Neuf(s) Paperback Quantité : 1
Vendeur
Herb Tandree Philosophy Books
(Stroud, GLOS, Royaume-Uni)
Evaluation vendeur
[?]

Description du livre Springer, 2012. Paperback. État : NEW. 9781461424918 This listing is a new book, a title currently in-print which we order directly and immediately from the publisher. N° de réf. du libraire HTANDREE0304214

Plus d'informations sur ce vendeur | Poser une question au libraire

Acheter neuf
EUR 247,16
Autre devise

Ajouter au panier

Frais de port : EUR 9,41
De Royaume-Uni vers France
Destinations, frais et délais

4.

Shire, Steven J.
Edité par Springer (2016)
ISBN 10 : 1461424917 ISBN 13 : 9781461424918
Neuf(s) Paperback Quantité : 1
impression à la demande
Vendeur
Ria Christie Collections
(Uxbridge, Royaume-Uni)
Evaluation vendeur
[?]

Description du livre Springer, 2016. Paperback. État : New. PRINT ON DEMAND Book; New; Publication Year 2016; Not Signed; Fast Shipping from the UK. No. book. N° de réf. du libraire ria9781461424918_lsuk

Plus d'informations sur ce vendeur | Poser une question au libraire

Acheter neuf
EUR 251,65
Autre devise

Ajouter au panier

Frais de port : EUR 3,30
De Royaume-Uni vers France
Destinations, frais et délais

5.

Steve Shire
Edité par Springer-Verlag New York Inc. (2012)
ISBN 10 : 1461424917 ISBN 13 : 9781461424918
Neuf(s) Quantité : > 20
impression à la demande
Vendeur
PBShop
(Wood Dale, IL, Etats-Unis)
Evaluation vendeur
[?]

Description du livre Springer-Verlag New York Inc., 2012. PAP. État : New. New Book.Shipped from US within 10 to 14 business days.THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. N° de réf. du libraire IP-9781461424918

Plus d'informations sur ce vendeur | Poser une question au libraire

Acheter neuf
EUR 250,07
Autre devise

Ajouter au panier

Frais de port : EUR 13,81
De Etats-Unis vers France
Destinations, frais et délais

6.

Edité par Springer-Verlag New York Inc., United States (2012)
ISBN 10 : 1461424917 ISBN 13 : 9781461424918
Neuf(s) Paperback Quantité : 10
impression à la demande
Vendeur
The Book Depository US
(London, Royaume-Uni)
Evaluation vendeur
[?]

Description du livre Springer-Verlag New York Inc., United States, 2012. Paperback. État : New. 2010 ed.. 254 x 178 mm. Language: English . Brand New Book ***** Print on Demand *****. Monoclonal antibodies represent one of the fastest growing areas of new drug development within the pharmaceutical industry. Several blockbuster products have been approved over the past several years including Rituxan, Remicade, Avastin, Humira, and Herceptin. In addition, over 300 new drugs are currently in clinical trials. With both large, established biotechnology companies and small start-ups involved in the development of this important class of molecules, monoclonal antibodies products will become increasingly prevalent over the next decade. Recently the regulatory review of monoclonal antibodies has been moved from Center for Biologics and Research to the Center for Drug Evaluation and Research (CDER) division of the US Food and Drug Administration. It is anticipated that CDER will expect a certain minimal amount of data to be provided as more of these products move through the regulatory pipeline.Current Trends in Monoclonal Antibody Development and Manufacturing will provide readers with an understanding of what is currently being done in the industry to develop, manufacture, and release monoclonal antibody products and what will be required for a successful regulatory submission. N° de réf. du libraire AAV9781461424918

Plus d'informations sur ce vendeur | Poser une question au libraire

Acheter neuf
EUR 253,84
Autre devise

Ajouter au panier

Frais de port : EUR 1,41
De Royaume-Uni vers France
Destinations, frais et délais

7.

Edité par Springer (2012)
ISBN 10 : 1461424917 ISBN 13 : 9781461424918
Neuf(s) Couverture souple Quantité : 15
impression à la demande
Vendeur
European-Media-Service Mannheim
(Mannheim, Allemagne)
Evaluation vendeur
[?]

Description du livre Springer, 2012. État : New. This item is printed on demand for shipment within 3 working days. N° de réf. du libraire LP9781461424918

Plus d'informations sur ce vendeur | Poser une question au libraire

Acheter neuf
EUR 285,46
Autre devise

Ajouter au panier

Frais de port : EUR 9,99
De Allemagne vers France
Destinations, frais et délais

8.

Edité par Springer (2012)
ISBN 10 : 1461424917 ISBN 13 : 9781461424918
Neuf(s) Paperback Quantité : 1
Vendeur
Irish Booksellers
(Rumford, ME, Etats-Unis)
Evaluation vendeur
[?]

Description du livre Springer, 2012. Paperback. État : New. book. N° de réf. du libraire 1461424917

Plus d'informations sur ce vendeur | Poser une question au libraire

Acheter neuf
EUR 343,30
Autre devise

Ajouter au panier

Frais de port : EUR 11,05
De Etats-Unis vers France
Destinations, frais et délais

9.

Shire, Steven J. (Editor)/ Gombotz, Wayne (Editor)/ Bechtold-peters, Karoline (Editor)/ Andya, James (Editor)
Edité par Springer Verlag (2012)
ISBN 10 : 1461424917 ISBN 13 : 9781461424918
Neuf(s) Paperback Quantité : 2
Vendeur
Revaluation Books
(Exeter, Royaume-Uni)
Evaluation vendeur
[?]

Description du livre Springer Verlag, 2012. Paperback. État : Brand New. 366 pages. 10.00x7.00 inches. In Stock. N° de réf. du libraire x-1461424917

Plus d'informations sur ce vendeur | Poser une question au libraire

Acheter neuf
EUR 354,17
Autre devise

Ajouter au panier

Frais de port : EUR 7,06
De Royaume-Uni vers France
Destinations, frais et délais

10.

Edité par Springer
ISBN 10 : 1461424917 ISBN 13 : 9781461424918
Neuf(s) Paperback Quantité : 20
Vendeur
BuySomeBooks
(Las Vegas, NV, Etats-Unis)
Evaluation vendeur
[?]

Description du livre Springer. Paperback. État : New. Paperback. 354 pages. Dimensions: 10.0in. x 7.0in. x 0.9in.Monoclonal antibodies represent one of the fastest growing areas of new drug development within the pharmaceutical industry. Several blockbuster products have been approved over the past several years including Rituxan, Remicade, Avastin, Humira, and Herceptin. In addition, over 300 new drugs are currently in clinical trials. With both large, established biotechnology companies and small start-ups involved in the development of this important class of molecules, monoclonal antibodies products will become increasingly prevalent over the next decade. Recently the regulatory review of monoclonal antibodies has been moved from Center for Biologics and Research to the Center for Drug Evaluation and Research (CDER) division of the US Food and Drug Administration. It is anticipated that CDER will expect a certain minimal amount of data to be provided as more of these products move through the regulatory pipeline. Current Trends in Monoclonal Antibody Development and Manufacturing will provide readers with an understanding of what is currently being done in the industry to develop, manufacture, and release monoclonal antibody products and what will be required for a successful regulatory submission. This item ships from multiple locations. Your book may arrive from Roseburg,OR, La Vergne,TN. Paperback. N° de réf. du libraire 9781461424918

Plus d'informations sur ce vendeur | Poser une question au libraire

Acheter neuf
EUR 413,30
Autre devise

Ajouter au panier

Frais de port : EUR 11,92
De Etats-Unis vers France
Destinations, frais et délais